3 recruiting, 3 unknown, 1 not yet recruiting. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Recruiting 3, Unknown 3, Not yet recruiting 1 |
Follow GLP-1 Receptor Agonist: new trials by email Literature Review of GLP-1 Receptor Agonist trials Research Report on GLP-1 Receptor Agonist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer GLP-1 Receptor Agonist, Levonorgestrel IUD (Lng-IUD), Oral Progestins - Endometrial Cancer, Endometrial Cancer Stage I | Phase 4 | Not yet recruiting | Hospital Universitari de Bellvitge | 80 | 2027-01-01 | 2026-06-10 |
| Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect) - Liver Cirrhoses, Portal Hypertension Related to Cirrhosis | Phase 4 | Recruiting | The Cleveland Clinic | 70 | 2025-12-17 | 2026-10-22 |
| Impact GLP-1 Agonists Following Bariatric GLP-1 receptor agonist - Morbid Obesity, Metabolic Syndrome | Phase 4 | Recruiting | University of Missouri-Columbia | 150 | 2024-02-01 | 2026-10-21 |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes SGLT2 inhibitor, GLP-1 receptor agonist - Type2Diabetes, ASCVD | Phase 4 | Recruiting | Brigham and Women's Hospital | 6000 | 2022-09-26 | 2026-04-13 |
| The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Beinaglutide, Dulaglutide - Diabetes Mellitus, Type 2, Overweight or Obesity | Phase 4 | Unknown | Second Xiangya Hospital of Central South University | 120 | 2021-05-01 | 2023-03-17 |
| Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients GLP-1 receptor agonist - Diabetes Mellitus, Type 2 | Phase 4 | Unknown | Dasman Diabetes Institute | 315 | 2020-03-01 | 2020-07-21 |
| Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy Exenatide, Metformin - Type 2 Diabetes | Phase 4 | Unknown | xiaolong zhao | 100 | 2014-02-01 | 2014-05-02 |
Diabetes Mellitus, Type 2 (3) · Obesity (2) · Obesity, Morbid (2) · Overweight (2) · Diabetes Mellitus (1) · Endometrial Hyperplasia (1) · Endometrial Neoplasms (1) · Hypertension (1) · Metabolic Syndrome (1) · Neoplasms (1) · Sleep Apnea, Obstructive (1) · Weight Loss (1)
Brigham and Women's Hospital (1) · Dasman Diabetes Institute (1) · Hospital Universitari de Bellvitge (1) · Second Xiangya Hospital of Central South University (1) · The Cleveland Clinic (1) · University of Missouri-Columbia (1) · xiaolong zhao (1)
United States (3) · China (2) · Kuwait (1)
Ali Aminian, MD (1) · Andrew Wheeler, MD (1) · Ebaa AlOzairi, MD, PhD (1) · Jorge Garcia Fernandez (1) · Lola Marti (1)